| Acquirer | Target | Price |
|---|---|---|
| Shire plc | Dyax Corp. | $5.9 billion |
| Bristol-Myers Squibb | Cardiopxyl Pharmaceuticals | $300 million |
| Pamplona Capital Management | MedAssets, Inc. | $2.7 billion |
| Envison Healthcare Holdings | Questcare Medical Services | $135 million |
| Sheridan Healthcare | Valley Anesthesiology & Pain Consultants | N/A |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
